The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs

Tadeusz Robak, Elżbieta Iskierka-Jażdżewska, Anna Puła, Pawel Robak, Bartosz Puła

Open source

DOI
10.3390/jcm14228247
Published
2025-11-20
Container
Journal of Clinical Medicine
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/jcm14228247,
  title = {The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs},
  author = {Tadeusz Robak and Elżbieta Iskierka-Jażdżewska and Anna Puła and Pawel Robak and Bartosz Puła},
  year = {2025},
  journal = {Journal of Clinical Medicine},
  doi = {10.3390/jcm14228247},
  url = {https://doi.org/10.3390/jcm14228247}
}

RIS

TY  - JOUR
TI  - The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs
AU  - Tadeusz Robak
AU  - Elżbieta Iskierka-Jażdżewska
AU  - Anna Puła
AU  - Pawel Robak
AU  - Bartosz Puła
PY  - 2025
JO  - Journal of Clinical Medicine
DO  - 10.3390/jcm14228247
UR  - https://doi.org/10.3390/jcm14228247
ER  - 

APA

Robak, T., Iskierka-Jażdżewska, E., Puła, A., Robak, P., & Puła, B. (2025). The Development of Novel Therapies for Chronic Lymphocytic Leukaemia in the Era of Targeted Drugs. Journal of Clinical Medicine. https://doi.org/10.3390/jcm14228247

Source records